Brian Feingold, MD, MS, FAHA
- Associate Professor of Pediatrics and Clinical and Translational Science
- Medical Director, Heart Failure and Transplantation Programs, UPMC Children's Hospital of Pittsburgh
Brian Feingold is a graduate of Duke University and the University of Pittsburgh School of Medicine. Feingold has over a decade of experience in outpatient and inpatient management of heart failure, pulmonary hypertension, and pre- and post-transplant care, including use of mechanical circulatory support. His research interests include care of the allosensitized patient, renal dysfunction after transplantation, cardiac involvement in Barth Syndrome, factors influencing progression to chronic allograft dysfunction/loss, and non-invasive assessment of acute rejection.
Feingold currently serves on councils/committees for the American Heart Association, International Society for Heart and Lung Transplantation, and the Organ Procurement and Transplant Network. He also is serves on the Scientific and Medical Advisory Boards of the Barth Syndrome Foundation and Enduring Hearts Foundation.
Professional and Scientific Society Memberships
- American Medical Association, 1995-2002, 2004-2007
- Massachusetts Medical Society, 1999-2002
- American Academy of Pediatrics, 1999-2002 (Fellow, 2005)
- International Pediatric Transplant Association, 2003-2017, 2019-Present
- American College of Cardiology, 2002-2008
- American Heart Association, 2004-Present (Fellow, 2016)
- American Society of Transplantation, 2006-Present
- International Society for Heart and Lung Transplantation, 2006-Present
- Heart Failure Society of America, 2006-2007
- Society for Pediatric Research, 2011-Present
Education & Training
- BS, Biology, Duke University, 1995
- MD, University of Pittsburgh, 1999
- Internship/Residency in Pediatrics, University of Massachusetts Memorial Medical Center, 1999-2002
- Fellowship in Pediatric Cardiology, UPMC Children's Hospital of Pittsburgh, 2002-2005
- Chief Fellow in Pediatric Cardiology, UPMC Children's Hospital of Pittsburgh, 2004-2005
- Fellowship in Pediatric Cardiac Transplantation and Heart Failure, UPMC Children's Hospital of Pittsburgh, 2005-2006
Fröjdh F, Fridman Y, Bering P Sayeed A, Maanja M, Niklasson L, Olausson E, Pi H, Azeem A, Wong TC, Kellman P, Feingold B, Christopher A, Fukui M, Cavalcante J, Miller CA, Butler J, Ugander M, Schelbert EB. Extracellular volume and global longitudinal strain both associate with outcomes but correlate minimally. JACC: Cardiovasc Imaging. In press.
Lambert AN, Weiner JG, Hall M, Thurm C, Dodd DA, Bearl DW, Soslow JH, Feingold B, Smith AH, Godown J. Rehospitalization following pediatric heart transplantation: Incidence, indications, and risk factors. Pediatr Cardiol. 2020. 41:584-590 PMID: 32103290.
McGreevy M, Wearden P, Feingold B, Nowalk A. Fever and inflammatory markers do not predict infection in pediatric ventricular assist device recipients. Prog Pediatr Cardiol. Mar 2020; 56:101197.
Beach C, Hart S, Nowalk A, Feingold B, Kurland K, Arora G. Increasing Burden of Lyme Carditis in United States Children’s Hospitals. Pediatr Cardiol. 2020. 41:258–64. PMID: 31728570.
Weiner JG, Lambert AN, Thurm C, Hall M, Soslow JH, Reimschisel TE, Bearl DW, Dodd DA, Feingold B, Godown J. Heart transplantation in children with mitochondrial disease. J Pediatr. 2020; 217:46-51. PMID: 31711761.
Magnetta DA, Godown J, West S, Zinn M, Rose-Felker K, Miller S, Feingold B. Impact of the 2016 Revision of US Pediatric Heart Allocation Policy on Waitlist Characteristics and Outcomes. Am J Transplant. Dec 2019; 19(12):3276-83. PMID: 31544351.
Mahle WT, Mason KL, Dipchand AI, Richmond M, Feingold B, Canter CE, Hsu DT, Singh TP, Shaddy RE, Armstrong BD, Zeevi A, Iklé DN, Diop H, Odim J, Webber SA for CTOTC-04 Investigators. Hospital readmission following pediatric heart transplantation. Pediatr Transplant. 2019; 23:e13561. PMID: 31483086.
Lamour JM, Mason KL, Hsu DT, Feingold B, Blume BD, Canter CE, Dipchand AI, Shaddy RE, Mahle WT, Zuckerman WA, Bentlejewski C, Armstrong BD, Morrison Y, Diop H, Ikle DN, Odim J, Zeevi A, Webber SA. et al. Early outcomes for low risk pediatric heart transplant recipients and steroid avoidance: a multicenter cohort study (Clinical Trials in Organ Transplantation in Children-CTOTC-04) Journal of Heart and Lung Transplantation. J Heart Lung Transplant. 2019. Sep;38(9):972-981. PMID: 31324444.
Singh A, Feingold B, Rivera-Lebron B, Weiner D, Drant S. Correlating Objective Echocardiographic Parameters in Patients with Pulmonary Hypertension due to Bronchopulmonary Dysplasia. J Perinatol. 2019 Sep;39(9):1282-1290. PMID: 31312036
West C, Maul TM, Feingold B, Morell VO. Right ventricular dominance is associated with inferior outcomes after the extracardiac Fontan. World J Pediatr Congenit Heart Surg. 2019. Jul;10(4):416-423 PMID: 31307314
Fontan Exercise Longitudinal Assessment (FUEL) Clinical Trial and Open Label Extension (FUEL-OLE), (PI, 10% effort), 2017-2019, Pediatric Heart Network (NIH/NHLBI), $65,000
Non-invasive, multimodal assessment of allograft rejection after pediatric heart transplantation, (PI, 8% effort), 2017-2020, Abbott Diagnostics and HIllman Transplant Foundation, $98,282